Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Chronic kidney outcomes associated with GLP-1 receptor agonists versus long-acting insulins among type 2 diabetes patients requiring intensive glycemic control: a nationwide cohort study

Fig. 1

Absolute standardized mean differences of baseline characteristics between GLP-RA and LAI groups before and after propensity score matching. Black vertical line indicates standardized mean difference of 0.1. Values (i.e., black dots or crosses) greater than 0.1 indicate statistically significant between-group difference in patient baseline characteristics

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840